Project description
Containing COVID-19 with rapid tests
Testing is a critical cornerstone of the COVID-19 response. While molecular tests were rolled out within a month of the virus being sequenced, these are laboratory based. Rapid tests are necessary to detect the presence of the virus anywhere. These rapid tests are also faster and cheaper. As such, these tests are vital to contain and fight COVID-19. With this in mind, the EU-funded KRONO project is developing a lyophilised assay for direct detection of the coronavirus from nasal swab samples. This test can be conducted anywhere. The project will test its lyophilised assay. Research will document quantified standards and performance evaluation data under its ISO13485 quality standard and generate data for Emergency Use Authorisation regulatory approval.
Fields of science
- natural sciencesbiological sciencesbiochemistrybiomoleculesnucleic acids
- medical and health sciencesclinical medicinesurgery
- natural sciencesbiological sciencesmicrobiologyvirology
- medical and health scienceshealth sciencesinfectious diseasesRNA virusescoronaviruses
- natural sciencesbiological sciencesbiochemistrybiomoleculesproteinsenzymes
Programme(s)
Topic(s)
Funding Scheme
IMI2-RIA - Research and Innovation actionCoordinator
13284 Marseille
France
See on map
Participants (4)
00149 Roma
See on map
PE28 0NJ Kimbolton
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
20250 Corte
See on map
PE28 0NJ Cambridgeshire
See on map